Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jesper Säfholm (Stockholm, Sweden), Jesper Säfholm, Johan Bood, Sven-Erik Dahlén, Mikael Adner. Prostacyclin IP receptor activation blocks hyperosmolar-induced bronchoconstriction in isolated human small airways. Eur Respir J 2016; 48: Suppl. 60, 5054

Member's Comments

No comment yet.

Related content which might interest you: Central role of AC6 in β2 agonist induced relaxation of human airway smooth muscle Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016 Endothelin-1-mediated contraction of mouse small airways is resistant to salbutamol, but sensitive to rosiglitazone Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Involvement of the BK channels/G proteins processes in the synergistic effects between anticholinergic agents and beta2-adrenoceptor agonists in airway smooth muscle Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 A comparison of beta2-adrenoceptor desensitisation induced by olodaterol and formoterol in human lung mast cells and airway smooth muscle cells Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 The effect of adenosine on VEGF release from airway smooth muscle from subjects with asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Serelaxin is a potent inhibitor of airway contraction and enhances β-adrenoceptor-mediated relaxation Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Effect of resolvin D1 on leukotriene D4-induced constriction of rat and human bronchioles Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Secretion of hyaluronic acid is mediated by muscarinic receptors in airway smooth muscle cells of patients with COPD Source: International Congress 2014 – Translational studies in COPD Year: 2014 Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 LATE-BREAKING ABSTRACT: The PDE4 inhibitor CHF-6001 and LAMAs cooperatively inhibit bronchoconstriction-induced remodeling in lung slices Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016 Prostaglandin E2 prevents mast cell dependent bronchoconstrictrion via the EP2 receptor in human small airways Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma Year: 2015 IL-13 induces glucocorticoid-insensitive hyperreactivity of human small airways Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Endothelin receptor B protects GM-CSF mRNA from degradation in human airway smooth muscle cells Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Activation of TRPV4 causes bronchoconstriction: A possible role in respiratory disease? Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism Source: International Congress 2017 – Novel mechanisms and treatments for asthma Year: 2017 Rhinovirus-induced IL-33 expression in asthmatic airway smooth muscle cells is TLR3-dependent and involves activation of TAK1 Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016 Epac1 and Epac2 regulate airway smooth muscle tone in mice Source: International Congress 2016 – Translational studies in lung disease Year: 2016 The anti-proliferative effect of hydrogen sulfide upon human airway smooth muscle in COPD Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014 The effect of JQ1/SGCBD01 upon c-Myc in human airway smooth muscle in asthma Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Activation of TRPV4 triggers ATP release and mast cell dependent contraction of airway smooth muscle (ASM) Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Year: 2015